Tobi FDA Approved Drugs
BETHKIS [TobramycinC18H37N5O9]
RX
- 300mg/4ml (inhalation solution)
Chiesi Usa IncOct 12, 2012
- Management of cystic fibrosis patients.
CORTISPORIN [HydrocortisoneC21H30O5 : Neomycin Sulfate : Polymyxin B Sulfate]
RX
- 1% : eq 3.5mg base/ml : 10,000 units/ml (otic suspension/drops)
Casper Pharma LlcApproved Prior To Jan 1, 1982
Monarch PharmsApproved Prior To Jan 1, 1982
Monarch PharmsApproved Prior To Jan 1, 1982
ERYTHROCIN [Erythromycin LactobionateC37H67NO13C12H22O12]
RX
- eq 1gm base/vial (injection injectable)
eq 500mg base/vial (injection injectable)
HospiraOct 31, 1986
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE [HydrocortisoneC21H30O5 : Neomycin Sulfate : Polymyxin B Sulfate]
RX
- 1% : eq 3.5mg base/ml : 10,000 units/ml (otic suspension/drops)
Amring PharmsMay 1, 2006
Bausch And LombDec 29, 1995
Sandoz IncAug 25, 1983
Bausch And LombDec 29, 1995
Sandoz IncAug 25, 1983
OTICAIR [HydrocortisoneC21H30O5 : Neomycin Sulfate : Polymyxin B Sulfate]
RX
- 1% : eq 3.5mg base/ml : 10,000 units/ml (otic suspension/drops)
Bausch And LombAug 28, 1996
TOBI PODHALER [TobramycinC18H37N5O9]
RX
- 28mg (inhalation powder)
NovartisMar 22, 2013
- Treatment of cystic fibrosis patients with pseudomonas aeruginosa.
TOBRAMYCIN [TobramycinC18H37N5O9]
RX
- 0.3% (ophthalmic solution/drops)
300mg/5ml (inhalation solution)
Bausch And LombNov 29, 1993
Fera PharmsSep 11, 2001
Somerset Theraps LlcJun 28, 2017
Akorn IncMay 28, 2014
Amneal PharmsJul 13, 2015
Lupin AtlantisMar 22, 2017
Teva Pharms UsaOct 10, 2013
Fera PharmsSep 11, 2001
Somerset Theraps LlcJun 28, 2017
Akorn IncMay 28, 2014
Amneal PharmsJul 13, 2015
Lupin AtlantisMar 22, 2017
Teva Pharms UsaOct 10, 2013
TOBREX [TobramycinC18H37N5O9]
RX
- 0.3% (ophthalmic solution/drops)
Novartis Pharms CorpApproved Prior To Jan 1, 1982
Sandoz IncDec 13, 1984
Sandoz IncDec 13, 1984
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.